PubRank

William E Barlow

Author PubWeight™ 183.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol 2009 9.39
2 Influence of computer-aided detection on performance of screening mammography. N Engl J Med 2007 8.58
3 Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002 6.28
4 Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol 2007 6.11
5 Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003 5.60
6 A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain. Arch Intern Med 2009 4.96
7 Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008 4.81
8 Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial. Lancet 2009 4.64
9 Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 2003 4.54
10 Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 2015 4.53
11 Performance benchmarks for screening mammography. Radiology 2006 4.41
12 Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 2006 3.95
13 Combination anastrozole and fulvestrant in metastatic breast cancer. N Engl J Med 2012 3.86
14 Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 2004 3.86
15 Effectiveness of computer-aided detection in community mammography practice. J Natl Cancer Inst 2011 3.62
16 Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 2005 3.06
17 Association between mammography timing and measures of screening performance in the United States. Radiology 2005 2.85
18 High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials. J Clin Oncol 2011 2.73
19 Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol 2009 2.61
20 Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 2005 2.51
21 American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. J Clin Oncol 2011 2.51
22 Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography. Radiology 2002 2.36
23 Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J Natl Cancer Inst 2014 2.30
24 Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA 2004 2.07
25 Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol 2003 2.02
26 Measuring the performance of markers for guiding treatment decisions. Ann Intern Med 2011 1.95
27 Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer 2006 1.92
28 Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography. Radiology 2005 1.87
29 Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology 2005 1.75
30 p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst 2006 1.74
31 Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst 2012 1.70
32 Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. J Clin Oncol 2009 1.67
33 Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst 2008 1.61
34 Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 2008 1.60
35 Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623. J Clin Oncol 2007 1.59
36 Training, quality assurance, and assessment of medical record abstraction in a multisite study. Am J Epidemiol 2003 1.55
37 Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease. Radiology 2002 1.53
38 Reoperation as a quality indicator in colorectal surgery: a population-based analysis. Ann Surg 2007 1.51
39 Evidence-based target recall rates for screening mammography. Radiology 2007 1.39
40 Current realities of delivering mammography services in the community: do challenges with staffing and scheduling exist? Radiology 2005 1.37
41 Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer 2014 1.34
42 Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 2010 1.33
43 Mammography surveillance following breast cancer. Breast Cancer Res Treat 2003 1.33
44 Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat 2010 1.29
45 Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005 1.27
46 Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004. Radiology 2010 1.24
47 Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain. Spine (Phila Pa 1976) 2010 1.22
48 Efficacy of acupuncture for chronic low back pain: protocol for a randomized controlled trial. Trials 2008 1.18
49 Variability of interpretive accuracy among diagnostic mammography facilities. J Natl Cancer Inst 2009 1.17
50 Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 2012 1.16
51 Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012. J Clin Oncol 2011 1.15
52 Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Res Treat 2010 1.14
53 Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 2002 1.12
54 Radiologist uncertainty and the interpretation of screening. Med Decis Making 2004 1.12
55 Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes. Contemp Clin Trials 2012 1.10
56 Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221). Breast Cancer Res Treat 2011 1.10
57 Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival. Cancer 2005 1.09
58 The association between obesity and screening mammography accuracy. Arch Intern Med 2004 1.06
59 Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002 1.06
60 Mammographers' perception of women's breast cancer risk. Med Decis Making 2005 1.03
61 A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338. Clin Breast Cancer 2008 1.02
62 Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. Clin Cancer Res 2009 1.01
63 Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr 2005 0.99
64 The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007). Contemp Clin Trials 2012 0.97
65 Assessing accuracy of mammography in the presence of verification bias and intrareader correlation. Biometrics 2005 0.96
66 Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev 2010 0.95
67 Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897. J Clin Oncol 2009 0.92
68 Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomarkers Prev 2014 0.92
69 Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome. Am J Pathol 2010 0.92
70 Characteristics of patients with chronic back pain who benefit from acupuncture. BMC Musculoskelet Disord 2009 0.92
71 Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev 2013 0.92
72 The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women. Contraception 2004 0.92
73 Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors. Breast Cancer Res Treat 2014 0.91
74 Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer. Breast Cancer Res Treat 2010 0.90
75 Is maternal periodontal disease a risk factor for preterm delivery? Am J Epidemiol 2009 0.89
76 Molecular imaging research in the outcomes era: measuring outcomes for individualized cancer therapy. Acad Radiol 2007 0.89
77 Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer. Clin Cancer Res 2010 0.89
78 Screening clinical breast examination: how often does it miss lethal breast cancer? J Natl Cancer Inst Monogr 2005 0.88
79 Longitudinal changes in bone density in relation to oral contraceptive use. Contraception 2003 0.88
80 Contrasting two frameworks for ROC analysis of ordinal ratings. Med Decis Making 2010 0.87
81 SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer. Breast Cancer Res Treat 2011 0.87
82 Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors. J Clin Exp Dermatol Res 2011 0.85
83 Maternal periodontal disease and risk of preeclampsia: a case-control study. Am J Hypertens 2009 0.84
84 Evaluating components of dental care utilization among adults with diabetes and matched controls via hurdle models. BMC Oral Health 2012 0.84
85 Using administrative data for epidemiological research: case study to identify persons with periodontitis. Periodontol 2000 2012 0.83
86 Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer. Patient Educ Couns 2013 0.83
87 A population-based study of periodontal care among those with and without diabetes. J Periodontol 2011 0.83
88 Promoting quality and evidence-based care in early-stage breast cancer follow-up. J Natl Cancer Inst 2014 0.82
89 Differences among the elderly in the treatment costs of colorectal cancer: how important is race? Med Care 2007 0.81
90 Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection? J Natl Cancer Inst Monogr 2005 0.80
91 Expanding developmental and behavioral services for newborns in primary care; Effects on parental well-being, practice, and satisfaction. Am J Prev Med 2004 0.80
92 Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy. Breast Cancer Res Treat 2014 0.80
93 Cross-sectional study of periodontal care and Glycosylated Hemoglobin in an insured population. Diabetes Care 2010 0.80
94 Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430. Oncologist 2012 0.79
95 A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102. Breast Cancer Res Treat 2013 0.78
96 Re: Breast cancer screening comes full circle. J Natl Cancer Inst 2005 0.77
97 Specificity of clinical breast examination in community practice. J Gen Intern Med 2007 0.77
98 A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. Arch Intern Med 2005 0.77
99 Effect of low-dose thiazide diuretics on plasma lipids: results from a double-blind, randomized clinical trial in older men and women. J Am Geriatr Soc 2003 0.77
100 Expanding developmental and behavioral services for newborns in primary care: program design, delivery, and evaluation framework. Am J Prev Med 2004 0.76
101 Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. Am J Epidemiol 2017 0.75